奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HALO 奥洛兹美医疗

盘前交易 05-21 05:49:15 EDT

44.97

+0.26

+0.58%

盘前45.38

+0.41+0.91%

04:58 EDT

最高45.07	最低44.30	成交量65.68万
今开44.85	昨收44.71	日振幅1.72%
总市值57.24亿	流通市值56.61亿	总股本1.27亿
成交额2,940万	换手率0.52%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HALO","market":"US","secType":"STK","nameCN":"奥洛兹美医疗","latestPrice":44.97,"timestamp":1716235200000,"preClose":44.71,"halted":0,"volume":656825,"hourTrading":{"tag":"盘前","latestPrice":45.38,"preClose":44.97,"latestTime":"04:58 EDT","volume":25,"amount":1134.5,"timestamp":1716281892971},"delay":0,"floatShares":125890862,"shares":127274000,"eps":2.41887,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.26,"latestTime":"05-21 05:49:15 EDT","open":44.85,"high":45.07,"low":44.3,"amount":29404587.246124998,"amplitude":0.017222,"askPrice":49.93,"askSize":100,"bidPrice":44.8,"bidSize":30,"shortable":3,"etf":0,"ttmEps":2.41887,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716298200000},"adr":0,"listingDate":1099285200000,"adjPreClose":44.97,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":45.38,"preClose":44.97,"latestTime":"04:58 EDT","volume":25,"amount":1134.5,"timestamp":1716281892971},"postHourTrading":{"tag":"盘后","latestPrice":44.97,"preClose":44.97,"latestTime":"18:01 EDT","volume":33164,"amount":1491386.1,"timestamp":1716242510520},"volumeRatio":0.606758672155545},"requestUrl":"/m/hq/s/HALO","defaultTab":"news","newsList":[{"id":"2434317772","title":"摩根大通证券公司：维持Halozyme Therapeutics(HALO.US)评级，由优于大市调整至优于大市评级, 目标价由72.00美元调整至71.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434317772","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434317772?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:05","pubTimestamp":1715191519,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Halozyme Therapeutics(HALO.US)评级，由优于大市调整至优于大市评级, 目标价由72.00美元调整至71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902052387e13df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902052387e13df3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433219077","title":"奥洛兹美医疗盘中异动 早盘股价大涨5.06%报43.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433219077","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433219077?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:32","pubTimestamp":1715175162,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时32分，奥洛兹美医疗股票出现波动，股价快速拉升5.06%。截至发稿，该股报43.30美元/股，成交量5.9176万股，换手率0.05%，振幅5.23%。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.32%。奥洛兹美医疗公司简介：奥洛兹美医疗有限公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。该信息摘要如下：HC Wainwright & Co.：重申Halozyme Therapeutics评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821324279268a21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821324279268a21&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433437747","title":"HC Wainwright & Co.：重申Halozyme Therapeutics(HALO.US)评级，由买入调整至买入评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433437747","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433437747?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:36","pubTimestamp":1715168215,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Halozyme Therapeutics(HALO.US)评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050819365787e04e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050819365787e04e65&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413462592","title":"奥洛兹美医疗2023财年实现净利润2.82亿美元，同比增加39.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413462592","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413462592?lang=zh_cn&edition=full","pubTime":"2024-02-23 00:26","pubTimestamp":1708619209,"startTime":"0","endTime":"0","summary":"12月31日，奥洛兹美医疗公布财报，公告显示公司2023财年净利润为2.82亿美元，同比增加39.60%；其中营业收入为8.29亿美元，同比增加25.61%，每股基本收益为2.13美元。从资产负债表来看，奥洛兹美医疗总负债16.49亿美元，其中短期债务32.20百万美元，资产负债比为1.06，流动比率为6.67。机构评级：截至2023年12月31日，当前有10家机构对奥洛兹美医疗目标价做出预测，其中目标均价为48.10美元，其中最低目标价为28.00美元，最高目标价为72.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022300265587afb30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022300265587afb30f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413422955","title":"奥洛兹美医疗盘中异动 早盘股价大涨5.18%报37.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413422955","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413422955?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:30","pubTimestamp":1708525846,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时30分，奥洛兹美医疗股票出现异动，股价快速上涨5.18%。截至发稿，该股报37.86美元/股，成交量5.7927万股，换手率0.05%，振幅0.50%。最近的财报数据显示，该股实现营业收入8.29亿美元，净利润2.82亿美元，每股收益2.13美元，毛利5.63亿美元，市盈率18.03倍。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.00%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221223046791322d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221223046791322d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413044357","title":"Halozyme Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2413044357","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413044357?lang=zh_cn&edition=full","pubTime":"2024-02-21 18:44","pubTimestamp":1708512240,"startTime":"0","endTime":"0","summary":"   * Halozyme Therapeutics Inc   公布的截至12月底的季度调整后每股收益为82美分，高于去年同期的每股收益48美分。十位分析师对该季度的平均预期是每股收益 83 美分。华尔街预期为每股收益 79 美分至 85 美分。* 营收同比增长 26.7%，达到 2.3104 亿美元；分析师预期为 2.3114 亿美元。* Halozyme Therapeutics Inc公布的本季度每股收益为65美分。* 公司报告的季度净收入为 8539 万美元。* Halozyme Therapeutics Inc 本季度股价下跌了 2.6%。华尔街对 Halozyme Therapeutics Inc 的 12 个月目标价中位数为 48.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412961461","title":"Halozyme Therapeutics Inc   预计每股收益83美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412961461","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412961461?lang=zh_cn&edition=full","pubTime":"2024-02-17 06:48","pubTimestamp":1708123685,"startTime":"0","endTime":"0","summary":"   * Halozyme Therapeutics Inc    将于2月20日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据8位分析师基于LSEG数据的平均预期，这家总部位于加利福尼亚州圣迭戈的公司的营收预计将从去年同期的1.815亿美元增长27.4%，达到2.3137亿美元。   * LSEG 分析师对 Halozyme Therapeutics Inc 的平均预期为每股收益 83 美分。* 华尔街对 Halozyme Therapeutics Inc 的 12 个月目标价中位数为 48.00 美元，高于其上次收盘价 35.91 美元。2月16日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409543402","title":"奥洛兹美医疗盘中异动 急速拉升5.03%报35.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409543402","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409543402?lang=zh_cn&edition=full","pubTime":"2024-02-06 22:50","pubTimestamp":1707231014,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日22时50分，奥洛兹美医疗股票出现异动，股价急速拉升5.03%。截至发稿，该股报35.38美元/股，成交量8.9886万股，换手率0.07%，振幅5.03%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，20%的券商给予持有建议，10%的券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体涨幅为0.05%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206225014790faca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206225014790faca9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404536608","title":"奥洛兹美医疗盘中异动 急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404536608","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404536608?lang=zh_cn&edition=full","pubTime":"2024-01-18 23:10","pubTimestamp":1705590608,"startTime":"0","endTime":"0","summary":"北京时间2024年01月18日23时10分，奥洛兹美医疗股票出现波动，股价快速下挫5.08%。截至发稿，该股报34.21美元/股，成交量20.2124万股，换手率0.15%，振幅6.19%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，20%的券商给予持有建议，10%的券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.62%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182310087a3c5341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182310087a3c5341&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404583124","title":"美国研究综述-苹果公司、Crane Nxt、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2404583124","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404583124?lang=zh_cn&edition=full","pubTime":"2024-01-18 20:06","pubTimestamp":1705579600,"startTime":"0","endTime":"0","summary":"    路透1月18日 - 华尔街证券分析师周四调整了对苹果公司、Crane Nxt 和 Netflix 等多家美国上市公司的评级和目标价。* Crane Nxt Co   ：D.A. Davidson将目标价从75美元上调至80美元  * Masonite International Corp   ：摩根大通将目标价从 115 美元上调至 120 美元  * Netflix Inc   ：Piper Sandler 将目标价从 400 美元上调至 475 美元              * Spirit Airlines Inc   ：花旗集团将其评级从 \"中性 \"下调至 \"卖出\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404522378","title":"美国研究综述-第一银行、Crane Nxt、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2404522378","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404522378?lang=zh_cn&edition=full","pubTime":"2024-01-18 14:52","pubTimestamp":1705560778,"startTime":"0","endTime":"0","summary":"    路透1月18日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Bank First、Crane Nxt 和 Netflix。要闻             * 第一银行  ：Piper Sandler将目标价从88美元上调至93美元              * Crane Nxt Co   ：D.A. Davidson将目标价从75美元上调至80美元              * Masonite International Corp   ：摩根大通将目标价从 115 美元上调至 120 美元              * Netflix Inc   ：Piper Sandler 将目标价从 400 美元上调至 475 美元              * Pinnacle Financial Partners Inc   ：Truist Securities将目标价从100美元下调至93美元  以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404351759","title":"奥洛兹美医疗盘中异动 早盘股价大跌5.05%报34.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404351759","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404351759?lang=zh_cn&edition=full","pubTime":"2024-01-17 22:42","pubTimestamp":1705502539,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日22时42分，奥洛兹美医疗股票出现波动，股价快速跳水5.05%。截至发稿，该股报34.53美元/股，成交量10.718万股，换手率0.08%，振幅3.48%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，20%的券商给予持有建议，10%的券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.29%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172242207a3bf97b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172242207a3bf97b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404899463","title":"BUZZ--美国股票走势-Halozyme、Scorpio Tankers、AMD(超威/超微)","url":"https://stock-news.laohu8.com/highlight/detail?id=2404899463","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404899463?lang=zh_cn&edition=full","pubTime":"2024-01-17 00:02","pubTimestamp":1705420962,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月16日 - 华尔街主要股指周二下跌，原因是高盛和摩根士丹利的财报喜忧参半，令投资者对资本市场和交易的健康状况持谨慎态度，银行股因此承压，而特斯拉和苹果的下跌也对股指造成了影响。美东时间 10:37，道琼斯工业平均指数  下跌 0.37%，报 37,452.44 点。标普500指数  和纳斯达克综合指数  下跌0.11%，报14,956.264点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403867836","title":"BUZZ-武田的神经紊乱药物获得 FDA 批准，Halozyme 公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2403867836","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403867836?lang=zh_cn&edition=full","pubTime":"2024-01-16 22:18","pubTimestamp":1705414720,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月16日 - ** 生物制药公司Halozyme   股价盘前上涨1.3%至34.88美元** 该公司称， (link) 武田  与HALO的给药技术共同配制的药物HYQVIA已获得美国FDA批准，用于治疗成人慢性炎症性脱髓鞘性多发性神经病(CIDP) ** 慢性炎症性脱髓鞘多发性神经病是一种神经系统疾病，会导致手脚进行性无力和感觉减退。** 2023 年股价下跌约 35","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2392925651","title":"奥洛兹美医疗盘中异动 快速下跌5.43%报37.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392925651","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392925651?lang=zh_cn&edition=full","pubTime":"2023-12-20 22:33","pubTimestamp":1703082783,"startTime":"0","endTime":"0","summary":"北京时间2023年12月20日22时33分，奥洛兹美医疗股票出现波动，股价快速跳水5.43%。截至发稿，该股报37.24美元/股，成交量7.3948万股，换手率0.06%，振幅4.53%。最近的财报数据显示，该股实现营业收入2.16亿美元，净利润81.84百万美元，每股收益0.62美元，毛利1.41亿美元，市盈率19.97倍。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为1.16%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312202233067a349bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312202233067a349bc3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391509419","title":"奥洛兹美医疗盘中异动 早盘股价大跌5.05%报39.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2391509419","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391509419?lang=zh_cn&edition=full","pubTime":"2023-12-14 23:26","pubTimestamp":1702567602,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日23时26分，奥洛兹美医疗股票出现异动，股价大幅下挫5.05%。截至发稿，该股报39.98美元/股，成交量29.867万股，换手率0.23%，振幅6.65%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，20%的券商给予持有建议，10%的券商给予卖出建议。奥洛兹美医疗股票所在的生物技术行业中，整体跌幅为0.79%。奥洛兹美医疗公司简介：奥洛兹美医疗公司是一家专注于开发和商业化新型肿瘤治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312142326437a33b48e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312142326437a33b48e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.halozyme.com","stockEarnings":[{"period":"1week","weight":0.0312},{"period":"1month","weight":0.1638},{"period":"3month","weight":0.2492},{"period":"6month","weight":0.1212},{"period":"1year","weight":0.3277},{"period":"ytd","weight":0.2167}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Halozyme Therapeutics, Inc.是一家生物制药公司,成立于1998年。2007年11月，该公司重组并注册于特拉华州（以前注册于内华达州）。该公司致力于创新产品的开发和商业化。公司研究细胞外基质、细胞外区域,包括细胞迁移、信号和存活。多年来,该公司已经开发了独特的科学专业知识, 允许其追求侧重于环境发展的治疗办法。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":-0.018251},{"month":2,"riseRate":0.6,"avgChangeRate":0.02437},{"month":3,"riseRate":0.5,"avgChangeRate":0.041397},{"month":4,"riseRate":0.619048,"avgChangeRate":-0.004965},{"month":5,"riseRate":0.571429,"avgChangeRate":0.010322},{"month":6,"riseRate":0.6,"avgChangeRate":0.042583},{"month":7,"riseRate":0.6,"avgChangeRate":0.028088},{"month":8,"riseRate":0.45,"avgChangeRate":-0.024855},{"month":9,"riseRate":0.35,"avgChangeRate":0.027274},{"month":10,"riseRate":0.5,"avgChangeRate":-0.019234},{"month":11,"riseRate":0.65,"avgChangeRate":0.069974},{"month":12,"riseRate":0.6,"avgChangeRate":0.124665}],"exchange":"NASDAQ","name":"奥洛兹美医疗","nameEN":"Halozyme Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥洛兹美医疗(HALO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥洛兹美医疗,HALO,奥洛兹美医疗股票,奥洛兹美医疗股票老虎,奥洛兹美医疗股票老虎国际,奥洛兹美医疗行情,奥洛兹美医疗股票行情,奥洛兹美医疗股价,奥洛兹美医疗股市,奥洛兹美医疗股票价格,奥洛兹美医疗股票交易,奥洛兹美医疗股票购买,奥洛兹美医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥洛兹美医疗(HALO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥洛兹美医疗(HALO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}